Generic placeholder image

Current Drug Therapy

Author(s): Umme Hani*, Yahya Alhamhoom, Ali Alqahtani, Riyaz Ali Osmani, Mohamed Rahamathulla, Yasmin Begum Mohammed and Ekta Singh

DOI: 10.2174/1574885515666200305101840

DownloadDownload PDF Flyer Cite As
In-vitro Comparative Study of Different Brands of Metoclopramide Hydrochloride Tablets Marketed in Saudi Arabia

Page: [512 - 517] Pages: 6

  • * (Excluding Mailing and Handling)

Abstract

Background: Metoclopramide hydrochloride (MCP), a derivative of para-aminobenzoic acid, which is a freely soluble drug, gets rapidly absorbed from the gastrointestinal tract and is used in the management of gastrointestinal disorders such as gastric stasis, gastroesophageal reflux and for the prevention of cancer chemotherapy induced emesis. Several brands of MCP are available in Saudi Arabia.

Objective: The objective of the present study was to evaluate the quality of different marketed products of MCP tablets 10mg, which were purchased from the retail pharmacy outlets in Abha, Riyadh and Jeddah, Saudi Arabia with a view to determine their interchangeability in clinical practice.

Methods: The study was carried out on branded tablets by quality control tests such as weight variation, hardness, friability, disintegration and dissolution. The results of all marketed products complied with the official specifications.

Results: The results showed that all the parameters for MCP tablets were in accordance with the USP limits. All the tested four brands were bioequivalent and complying with the official tests for weight variation, friability, disintegration and dissolution tests. The percent friability was also within the specified limit. Moreover, all formulations disintegrated within 2-6 min. The percentage content of the active ingredient of four brands of MCP tablets showed values within the monograph specifications (95-105%).

Conclusion: All the four brands evaluated in the present work could be considered bio pharmaceutically equivalent and therefore, patients can safely switch from one brand to another when there is the unavailability of a particular brand.

Keywords: Tablets, metoclopramide, gastrointestinal reflux disease, quality control, bioequivalence, chemotherapy.

Graphical Abstract

[1]
Hasan A, Dewan SAR, Ahamed SK, Kai MM. Quality control studies on cetirizine hydrochloride tablets available in Bangladesh drug market. Int J Pharma Bio Sci 2013; 3(1): 349354-2.
[2]
Nasrin N, Asaduzzaman M, Mowla R, Rizwan F, Alam A. A comparative study of physical parameters of selected ketorolac tromethamine tablets available in the pharma market of Bangladesh. J Appl Pharm Sci 2011; 1(8): 101-3.
[3]
Afifi SA, Ahmadeen S. A comparative study for evaluation of different brands of metformin hydrochloride 500mg tablets marketed in Saudi araba. Life Sci J 2012; 9(4): 4260-6.
[4]
Rahamathulla M. Comparative assessment of different marketed brands of atorvastatin tablets in Asir region, Saudi Arabia. MOJ Drug Des Develop Ther 2018; 2(1): 9-13.
[5]
Webmd.com/drug/2/drug-8679/Metoclopramide-oral/detail
[6]
Leigh A. Guide to Metoclopramide Benefits and Risks of Metoclopramide, Bright Hub https://brighthub.com2009.
[7]
Banker GS, Anderson NR. The theory and practice of industrial pharmacy 2011; 10: 293-345.
[8]
Kumar D, Singh J, Antil M, Kumar V. Quality control of tablets: A review. Int J Uni Pharm Bio Sci 2016; 5(4): 53-67.
[9]
Jannath S, Nayeema I, Jahan N, Deepa KN. Comparative Performance Evaluation of Different Brands of Ketorolac Tromethamine (NSAID’S) Generic Tablet. Advances in bioequivalence and bioavailability 2018; 1(2): 1-5.
[10]
Samar AA, Shaimaa A. Comparative study for evaluation of different brands of metformin hydrochloride 500 mg tablets marketed in Saudi Arabia. Life Sci J 2012; 9(4)
[11]
Olayemi SO, Akinleye MO, Awodele EO, Idris O, Oladimeji-Salami J. The physicochemical equivalence of eight brands of amlodipine tablets in Lagos, Nigeria. West Afr J Med 2012; 31(3): 154-9.
[PMID: 23310934]
[12]
Reem K, Khan A. Comparative in vitro pharmaceutical evaluation of four brands of metronidazole tablets marketed in gulf region. Jordan J Pharm Sci 2014; 7: 1-6.